These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1141600)

  • 1. Conformation of valinomycin in a triclinic crystal form.
    Karle IL
    J Am Chem Soc; 1975 Jul; 97(15):4379-86. PubMed ID: 1141600
    [No Abstract]   [Full Text] [Related]  

  • 2. The crystal and molecular structure of the triclinic and monoclinic forms of valinomycin, C54H90N6O18.
    Smith GD; Duax WL; Langs DA; DeTitta GT; Edmonds JW; Rohrer DC; Weeks CM
    J Am Chem Soc; 1975 Dec; 97(25):7242-7. PubMed ID: 1194598
    [No Abstract]   [Full Text] [Related]  

  • 3. Crystal structure of peptide cyclo-(D-Val-L-Pro-L-Val-D-Pro).
    Hamilton JA; Sabesan MN; Gisin BF; Steinrauf LK
    Biochem Biophys Res Commun; 1978 Feb; 80(4):949-54. PubMed ID: 637880
    [No Abstract]   [Full Text] [Related]  

  • 4. Solvent-dependent conformations of valinomycin in solution.
    Patel DJ; Tonelli AE
    Biochemistry; 1973 Jan; 12(3):486-96. PubMed ID: 4683491
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular structure of cyclo[-(D-Val-L-Hyi-L-Val-D-Hyi)2-] revealed by x-ray analysis.
    Grochulski P; Smith GD; Langs DA; Duax WL; Pletnev VZ; Ivanov VT
    Biopolymers; 1992 Jul; 32(7):757-64. PubMed ID: 1391629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal and molecular structure of the depsipeptide ionophore hexadecaisoleucinomycin, cyclo-[(D-Ile-L-Lac-L-Ile-D-Hyi)4-] (C80H136N8O24).
    Pletnev VZ; Ivanov VT; Langs DA; Strong P; Duax WL
    Biopolymers; 1992 Jul; 32(7):819-27. PubMed ID: 1391633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A small-angle X-ray diffraction study of valinomycin and its potassium isothiocyanate complex in solution.
    Krigbaum WR; Kuegler FR; Oelschlaeger H
    Biochemistry; 1972 Nov; 11(24):4548-52. PubMed ID: 4654142
    [No Abstract]   [Full Text] [Related]  

  • 8. Conformations of an ion-binding cyclic peptide analogue of valinomycin, cyclo(L-Val-Gly-Gly-L-Pro)3.
    Easwaran KR; Pease LG; Blout ER
    Biochemistry; 1979 Jan; 18(1):61-7. PubMed ID: 420778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular conformation of a D,L stereoisomeric analogue of valinomycin, cyclo[-(L-Val-L-Hyi-L-Val-D-Hyi)2-(D-Val-L-Hyi-L-Val-D-Hyi)-].
    Langs DA; Grochulski P; Duax WL; Pletnev VZ; Ivanov VT
    Biopolymers; 1991 Mar; 31(4):417-23. PubMed ID: 1863693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational characteristics of peptides and unanticipated results from crystal structure analyses.
    Karle IL
    Biopolymers; 1989 Jan; 28(1):1-14. PubMed ID: 2720096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Crystallization and molecular structure of cyclic dodecadepsipeptide cyclo]D-Val-D-Hyi-Val-Hyi-(D-Val-Hyi-Val-D-Hyi)2-].2C3H60].
    Pletnev VZ; Tsygannik IN; Mikhaĭlova IIu; Ivanov VT; Lengs DA; Grokhul'skiĭ P; Diuéks VL
    Bioorg Khim; 1991 Mar; 17(3):359-71. PubMed ID: 2064628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Structure of macrocyclic K+, Rb+-complexon of meso-valinomycin monohydrate, cyclo[-(D-Val-Hyi-Val-D-Hyi)3-].H2O, in a crystalline complex with dioxane by x-ray structural data].
    Pletnev VZ; Tsygannik IN; Fonarev IuD; Ivanov VT; Lengs DA; Grokhul'skiĭ P; Dukes VL
    Bioorg Khim; 1992 Jun; 18(6):794-801. PubMed ID: 1417998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valinomycin-cation complex. Conformational energy aspects.
    Mayers DF; Urry DW
    J Am Chem Soc; 1972 Jan; 94(1):77-81. PubMed ID: 5007249
    [No Abstract]   [Full Text] [Related]  

  • 14. Crystal structures and conformations of the cyclic dipeptides cyclo-(Glycyl-L-tyrosyl) and cyclo-(L-seryl-L-tyrosyl) Monohydrate.
    Lin Chi-Fan ; Webb LE
    J Am Chem Soc; 1973 Oct; 95(20):6803-11. PubMed ID: 4746276
    [No Abstract]   [Full Text] [Related]  

  • 15. The crystal and molecular structure of a valinomycin analogue cyclo[(D-Val-L-Lac-L-Ala-D-Hyi)2(D-Val-L-Lac-L-Val-D-Hyi)]. H2O(C50H82N6 O18.H2O).
    Pletnev VZ; Ruzeinikov SN; Tsigannik IN; Ivanov VT; Pletnev SV; Langs DA; Duax WL
    Biopolymers; 1997 Nov; 42(6):651-8. PubMed ID: 9358731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The conformation of the sodium complex of a biologically active analog of antamanide in the crystalline state.
    Karle IL
    Biochemistry; 1974 May; 13(10):2155-62. PubMed ID: 4826889
    [No Abstract]   [Full Text] [Related]  

  • 17. Peptides in molecular recognition: synthetic and conformational aspects.
    Giralt E; Albericio F; García-Echeverría C; Pons M; Royo M; Ruiz-Gayo M
    Biochem Soc Trans; 1994 Nov; 22(4):1045-8. PubMed ID: 7698404
    [No Abstract]   [Full Text] [Related]  

  • 18. Crystal structure and molecular conformation of the hydrated cyclic hexapeptide cyclo(L-Ala-L-Pro-D-Phe)2.
    Brown JN; Teller RG
    J Am Chem Soc; 1976 Nov; 98(24):7565-9. PubMed ID: 993495
    [No Abstract]   [Full Text] [Related]  

  • 19. Conformational studies of peptide cyclo-(D-Val-L-Pro-L-Val-D-Pro]3, a cation-binding analogue of valinomycin.
    Davis DG; Gisin BF; Tosteson DC
    Biochemistry; 1976 Feb; 15(4):768-74. PubMed ID: 1247533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure of [D-Hyi2,L-Hyi4]meso-valinomycin revealed by X-ray analysis.
    Pletnev VZ; Mikhailova IYu ; Ivanova VT; Langs DA; Grochulski P; Duax WL
    Biopolymers; 1991 Mar; 31(4):409-15. PubMed ID: 1863692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.